Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells

Abstract excerpt

Kallikrein 6 (KLK6) is a trypsin-like serine peptidase whose relevance in various types of cancers is currently being explored. Previous studies have shown that KLK6 mRNA is upregulated in colon and gastric cancers; however, the regulatory mechanisms and phenotypic consequences of this upregulation are largely unknown. Activating K-RAS mutations are common in colon cancer, occurring in approximately 50% of cases....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
• Share to Peptidase Inhibition and Analysis
• Share to PI3K/AKT/mTOR signaling in cancer